Skip to content

Opioid-free anaesthesia to reduce postoperative nausea and vomiting after lower extremity wound surgery: a randomised double-blind crossover trial.

Ya-Juan Zhu, Yao-Yu Ying, Hua-Yue Liu, Long Qian, Hong Liu, Fu-Hai Ji, Ke Peng

Annals of medicine December 1, 2025 DOI: 10.1080/07853890.2025.2517819 via PubMed

Summary

AI-generated from the abstract

Opioid-free anaesthesia (OFA) reduces postoperative nausea and vomiting (PONV) compared with opioid-inclusive anaesthesia in adults undergoing lower extremity wound surgery. In a randomized double-blind crossover trial, 66 patients each received both OFA (lidocaine, esketamine, dexmedetomidine, propofol) and opioid-inclusive anaesthesia (sufentanil, propofol) for two separate surgeries. OFA lowered the incidence of PONV during the first 48 hours after surgery (5% vs. 23%), and also reduced the severity of PONV and rate of hypotension, though time to extubation was longer. Postoperative pain and need for rescue analgesia did not differ between the two techniques.

Study at a glance

Characteristics Randomized double-blind crossover trial Peer reviewed
Sample size 66
Population Adult patients undergoing two surgical procedures for lower extremity wounds under general anaesthesia
Interventions esketamine dexmedetomidine and propofol) Opioid-inclusive anaesthesia (sufentanil and propofol)
Duration 48-hour postoperative follow-up; median washout period of 9 days between crossover arms
Keywords Lower extremity Opioid-free anaesthesia Wound surgery Anesthesia anaesthesia Postoperative nausea ponv
Citations 7
Key finding Opioid-free anaesthesia reduced the incidence of postoperative nausea and vomiting compared with opioid-inclusive anaesthesia (5% vs. 23%, odds ratio 0.13).

Abstract

Postoperative nausea and vomiting (PONV) are common complications after surgery. Opioid use is a significant risk factor. We utilised a crossover design to test this hypothesis in the same individuals that opioid-free anaesthesia (OFA) compared with opioid-inclusive anaesthesia reduces PONV. This randomised double-blind crossover trial included adult patients undergoing two surgical procedures for lower extremity wounds under general anaesthesia. Each patient received both OFA (i.v. lidocaine, esketamine, dexmedetomidine and propofol) and opioid-inclusive anaesthesia (sufentanil and propofol); which came first was determined by randomisation. The primary outcome was the incidence of PONV during the first 48 h postoperatively. Secondary outcomes were the severity of PONV, use of rescue antiemetics, postoperative pain, need for rescue analgesia, adverse events, time to extubation, and length of recovery room stay. Sixty-six patients completed this study (mean age 53 years, 36% female). The median washout period was 9 days. Compared with opioid-inclusive anaesthesia, OFA reduced the incidence of PONV 0-48 h postoperatively (5% vs. 23%, odds ratio [OR] = 0.13, 95% CI: 0.03-0.55, p = 0.006), which remained significant in the prespecified adjusted analysis (OR = 0.06, 95% CI: 0.01-0.32, p = 0.001). OFA also led to a reduced severity of PONV, a lower rate of hypotension, and a longer time to extubation. Postoperative pain and other outcomes were similar between the two anaesthetic techniques. This crossover trial demonstrates that OFA reduced PONV following lower extremity wound surgery, providing compelling evidence for the administration of OFA to enhance perioperative care. ChiCTR2200061511 (https://www.chictr.org.cn).

Comments

No comments yet.

Log in to comment